Analyst Reco. Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Real-time Estimate Cboe BZX Other stock markets 11:38:28 2024-05-17 am EDT			5-day change	1st Jan Change
6.6 ^USD	+1.38%		+2.65%	-40.15%

May. 14	Transcript : Relay Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM
May. 10	Barclays Upgrades Relay Therapeutics to Overweight From Equalweight With $15 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Upgrades Relay Therapeutics to Overweight From Equalweight With $15 Price Target	May. 10	MT
Oppenheimer Adjusts Relay Therapeutics Price Target to $25 From $33, Maintains Outperform Rating	May. 06	MT
HC Wainwright Adjusts Price Target on Relay Therapeutics to $17 From $19, Keeps Buy Rating	Dec. 11	MT
HC Wainwright Lowers Price Target on Relay Therapeutics to $19 From $33, Maintains Buy Rating	Nov. 08	MT
HC Wainwright Adjusts Price Target on Relay Therapeutics to $30 From $32, Keeps Buy Rating	23-08-17	MT
Berenberg Bank Adjusts Relay Therapeutics Price Target to $28 From $40, Maintains Buy Rating	23-04-26	MT
Jefferies Upgrades Relay Therapeutics to Hold From Underperform, Adjusts Price Target to $12.50 From $16	23-04-20	MT
Stifel Adjusts Price Target on Relay Therapeutics to $34 From $38, Maintains Buy Rating	23-04-20	MT
JPMorgan Adjusts Price Target on Relay Therapeutics to $29 From $42, Keeps Overweight Rating	23-04-19	MT
Raymond James Upgrade Relay Therapeutics to Strong Buy Rating From Outperform, Price Target is $29	23-04-19	MT
Barclays Cuts Price Target on Relay Therapeutics to $15 From $23, Keeps Equalweight Rating	23-04-19	MT
Raymond James Initiates Relay Therapeutics at Outperform With $29 Price Target	23-04-13	MT
JPMorgan Adjusts Price Target on Relay Therapeutics to $42 From $45, Maintains Overweight Rating	23-04-05	MT
HC Wainwright Adjusts Price Target on Relay Therapeutics to $46 From $43, Maintains Buy Rating	23-03-07	MT
Berenberg Bank Adjusts Relay Therapeutics' Price Target to $40 From $45, Maintains Buy Rating	23-03-01	MT
Oppenheimer Initiates Coverage on Relay Therapeutics With Outperform Rating, $33 Price Target	23-02-03	MT
JMP Securities Adjusts Price Target on Relay Therapeutics to $28 From $38, Maintains Market Outperform Rating	23-01-19	MT
HC Wainwright Adjusts Price Target on Relay Therapeutics to $43 From $50, Maintains Buy Rating	22-11-07	MT
Barclays Starts Relay Therapeutics at Equalweight With $23 Price Target	22-09-30	MT
JMP Securities Adjusts Price Target on Relay Therapeutics to $38 From $35, Maintains Market Outperform Rating	22-09-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Analyst Reco.

Filters